CLTX Insider Trading Activity and SEC Form 4 Filings
CLTX insider trading summary
No open-market insider purchases or sales of Celsus Therapeutics Plc. (CLTX) have been reported on SEC Form 4 in the past 12 months.
Latest CLTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 15, 2014 | Hal Mintz | 10% Owner | Buy | $86K (17,100 @ $5.00) |
| Apr 15, 2014 | Sabby Management, LLC | 10% Owner | Buy | $86K (17,100 @ $5.00) |
| Apr 15, 2014 | Sabby Healthcare Volatility Master Fund, Ltd. | 10% Owner | Buy | $86K (17,100 @ $5.00) |
| Apr 14, 2014 | Hal Mintz | 10% Owner | Buy | $16K (3,000 @ $5.21) |
| Apr 14, 2014 | Sabby Management, LLC | 10% Owner | Buy | $16K (3,000 @ $5.21) |
| Apr 14, 2014 | Sabby Healthcare Volatility Master Fund, Ltd. | 10% Owner | Buy | $16K (3,000 @ $5.21) |
| Apr 11, 2014 | Sabby Management, LLC | 10% Owner | Buy | $515 (100 @ $5.15) |
| Apr 11, 2014 | Sabby Healthcare Volatility Master Fund, Ltd. | 10% Owner | Buy | $515 (100 @ $5.15) |
| Apr 11, 2014 | Hal Mintz | 10% Owner | Buy | $515 (100 @ $5.15) |
| Apr 10, 2014 | Hal Mintz | 10% Owner | Buy | $7K (1,400 @ $5.25) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.